老年高血脂症强化降脂治疗应用阿托伐他汀和洛伐他汀的效果和安全性分析  

Analysis of the Efficacy and Safety of Lipid-lowering Therapy with Atorvastatin and Lovastatin in Elderly Hyperlipidemia Enhancement

作　　者：张锋[1] 靳雪松[2] 杨柳青[1] 王军[1] 

机构地区：[1]中国人民解放军61195部队门诊部 [2]中国人民解放军61195部队后勤部

出　　处：《中国医药指南》2016年第19期15-15,17,共2页Guide of China Medicine

摘　　要：目的探讨分析在老年高血脂症患者强化降脂治疗过程中应用阿托伐他汀和洛伐他汀治疗的临床疗效。方法选取来我门诊部就诊的老年高血脂症患者120例,分为实验组和对照组,对照组患者采用洛伐他汀强化降脂治疗,而实验组采用阿托伐他汀强化降脂治疗,比较两组患者治疗前后LDL-C、HDL-C、TG、TC指标及治疗过程中不良反应发生率。结果治疗后实验组患者的改善程度明显优于对照组。结论对老年高血脂症强化降脂治疗应用阿托伐他汀的临床疗效显著,安全性高,是降脂的首选用药,值得临床推广和使用。Objective To investigate the clinical efficacy of lipid-lowering therapy to strengthen the analysis applied during atorvastatin and lovastatin therapy in elderly patients with hyperlipidemia. Method Select to elderly patients with hyperlipidemia my clinic for treatment of 120 cases were divided into experimental and control groups, the control group were treated with lovastatin intensive lipid-lowering therapy, while the experimental group atorvastatin intensive lipid-lowering therapy, compare two LDL-C, HDL-C, TG, TC index and the course of treatment incidence of adverse reactions in patients before and after treatment. Results The experimental group was better than control group. Conclusion Elderly hyperlipidemia intensive lipid-lowering therapy applications atorvastatin clinical effects of statins significantly high safety, it is the preferred lipid-lowering medication, and is worthy of clinical use.

关 键 词：老年高血脂 阿托伐他汀他 洛伐他汀 效果 

分 类 号：R972.6[医药卫生—药品] R589.2[医药卫生—药学]